Observational study on postpartum hypertension
Official title: Swiss Postpartum Hypertension Cohort (Swiss-PPHT)
Run by University Hospital, Basel, Switzerland · NCT04690660 · Data updated 2026-11-12
This study looks at how high blood pressure after giving birth affects women's heart and kidney health over time and tries to find out what factors might increase their risk.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 480 (estimated) |
| Sponsor | University Hospital, Basel, Switzerland Academic / other |
| Locations | 1 site (Basel) |
| Status | Recruiting |
| Started | June 4, 2020 |
| Main results expected | May 2030 |
| Study ends | May 2030 |
| Registry record updated | May 28, 2025 |
| Trial ID | NCT04690660 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include women with hypertensive disorders during pregnancy, including those with postpartum hypertension or preexisting hypertension.
✕Probably not a fit
Patients who delivered more than 14 days prior or those unable to provide consent may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the short-, intermediate-, and long-term effects of postpartum hypertension, focusing on identifying predictors and risk factors associated with cardiovascular and renal health. It involves data collection on blood pressure measurements, organ damage markers, and patient-reported outcomes. Additionally, there will be a home-based blood pressure management substudy to evaluate current disease management strategies.
Why it matters
Potential benefit: If successful, this study could lead to improved management and outcomes for women experiencing postpartum hypertension.
How similar studies have gone: While there have been studies on postpartum hypertension, this specific observational approach focusing on long-term outcomes and home monitoring is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * all women with hypertensive disorders of pregnancy * postpartum hypertension (blood pressure measurements of systolic ≥140 and/or diastolic ≥ 90mmHg or antihypertensive therapy within the first 14 days after delivery) * women with preexisting hypertension or * women on antihypertensive medication Exclusion Criteria: * delivery \> 14 days * lack of consent to participate in the study, language barriers or lack of general understanding
Where it's running
-
Medical Outpatient Department and Hypertension Clinic, University Hospital Basel
Basel, Switzerland Recruiting
Study contacts
- Principal investigator: Thenral Socrates, Dr. med. — Medical Outpatient Department and Hypertension Clinic, University Hospital BaselUni
- Study coordinator: Thenral Socrates, Dr. med.
- Email: thenral.socrates@usb.ch
- Phone: +41 61 328 6647
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Postpartum high blood pressure: which medicine works better after delivery
This trial tests whether extended-release nifedipine works better than labetalol to control blood pressure after giving birth.
-
Predicting bowel leaks after colorectal surgery with a computer model and surgeon input
This study tests a computer model that predicts anastomotic leaks after colorectal surgery, and sees if adding surgeons’ intuition improves the predictions.
-
Active surveillance after immunotherapy for MMR-deficient colorectal and GI cancers
This study looks at whether some patients with non-metastatic, MMR-deficient or MSI-H colorectal cancers can skip surgery after a strong response to immunotherapy.
-
PCI Registry at University Hospital Basel for Complex Coronary Procedures
This registry collects real-world data from adults undergoing percutaneous coronary interventions at University Hospital Basel to see how different treatments like drug-eluting stents, drug-coated balloons, and bioresorbable scaffolds perform in diverse patients.
-
Severe Complications During VT/PVC Ablation
This study looks at real-world cases to see what severe complications occur during VT or PVC ablations and how patients are managed afterward.
-
Visioning III: Five-year follow-up for MRI-based prostate cancer screening
This study tests a repeat MRI-based screening approach for men who previously had no cancer signs, to see if a negative bpMRI reliably predicts no significant cancer for at least five years.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.